Pediatric Vaccine Market Growth Trajectory Through 2024-2033

The Pediatric Vaccine by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Pediatric Vaccine Market:
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

According to The Business Research Company’s Pediatric Vaccine, The pediatric vaccine market size has grown strongly in recent years. It will grow from $49.89 billion in 2023 to $53.52 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, immunization policies to eradicate endemic diseases, increased funding for vaccine development.

The pediatric vaccine market size is expected to see rapid growth in the next few years. It will grow to $83.49 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing cases of invasive cervical cancer, strong late-stage pipeline and new drug approvals, increasing prevalence of infectious diseases. Major trends in the forecast period include developing combination vaccines to meet market demand, consider investing r&d activities for the development of effective vaccines and development of vaccines for the young population, focusing on developing live attenuated vaccines for long term immunity protection of patients, utilizing new immunoengineering and advance delivery systems to formulate their vaccines to improve safety and implementing artificial intelligence (ai) in vaccine development to simplify the process and make manufacturing easy.

The rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below will contribute to the growth of the pediatric vaccines market. The risk of severe disease outcomes and complications of infectious diseases are increasing in children and adolescents with chronic conditions. in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-governing statutory body entrusted with gathering and evaluating data and providing factual recommendations, about half of the overall population (46.6%, or 11.6 million) had at least one chronic condition. The increased prevalence of chronic diseases among children rises the demand for immunization from chronic diseases, hence, driving the growth of the pediatric vaccine market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer

The demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g., tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest for pediatric vaccine manufacturers and developers for the innovation of vaccine design and manufacturing technologies. For instance, in April 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company announced the U.S. FDA approval of REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants.

The pediatric vaccine market report table of contents includes:

1. Executive Summary
2.Pediatric Vaccine Market Characteristics
3.Pediatric Vaccine Market Trends And Strategies
4.Pediatric Vaccine Market analyis
5. Pediatric VaccineMarket Size And Growth
6.Pediatric Vaccine Segmentation
7.Pediatric Vaccine Regional And Country Analysis
.
.
.
27. Pediatric VaccineCompetitive Landscape And Company Profiles
28.Pediatric Vaccine Key Mergers And Acquisitions
29.Pediatric Vaccine Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• Merck & Co. Inc.
• Serum Institute of India Pvt. Ltd.
• Sanofi SA
• Pfizer Inc.
• AstraZeneca

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model